Nydiagnosticeret melanom diagnosticeret på basis af kutanediagnosticeret på basis af kutane bivirkninger efter COVID-19-bivirkninger efter COVID-19- vaccinationvaccination

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Dokumenter

  • Fulltext

    Forlagets udgivne version, 329 KB, PDF-dokument

While the Danish Health Authority has withdrawn the vaxzevria vaccine from the Danish vaccination programme due to reports of rare cases of severe side effects, this case report presents a potential beneficial side effect of this vaccine. A patient presented, three days after her first jab, with localized itching and bleeding from a pigmented tumour on her lower leg, which was therefore excised, and, unexpectedly, diagnosed as a melanoma. We speculate if the vaccine-induced immune reaction resulted in increased immune activity within the tumour environment, and thus facilitated the early diagnosis of melanoma.

Bidragets oversatte titelNewly diagnosed melanoma diagnosed on the basis of cutaneous side effects from COVID-19 vaccine
OriginalsprogDansk
ArtikelnummerV01220060
TidsskriftUgeskrift for Laeger
Vol/bind184
Udgave nummer22
Antal sider5
ISSN0041-5782
StatusUdgivet - 2022

    Forskningsområder

  • COVID-19/prevention & control, COVID-19 Vaccines, Early Detection of Cancer, Female, Humans, Melanoma/diagnosis, Skin Neoplasms/diagnosis

ID: 325712476